12:00 AM
 | 
May 13, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Ampion: Phase III ongoing

Ampio completed enrollment of over 320 patients in the first, run-in portion of the 2-part, double-blind, placebo-controlled Phase III SPRING trial evaluating 4 and 10 mL intra-articular injections of Ampion. The run-in portion will determine...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >